Attovia Therapeutics Inc. (ATTO)
NasdaqGM: ATTO
· Real-Time Price · USD
20.70
-0.76 (-3.54%)
At close: Aug 28, 2026, 3:59 PM
20.70
+0.00%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Attovia Therapeutics Inc. (ATTO) Stock Price, Analysis & Data
-3.54% (1D)
| Bid | n/a |
| Market Cap | 890.7M |
| Revenue (ttm) | 1.35M |
| Net Income (ttm) | -64.13M |
| n/a | |
| -2.5 | |
| n/a | |
| n/a | |
| P/B (ttm) | -0.74 |
| P/S (ttm) | 659.78 |
| Earnings Date | n/a |
| Ask | n/a |
| Volume | 127,603 |
| Avg. Volume (20D) | 563,029 |
| Open | 21.37 |
| Previous Close | 21.46 |
| Day's Range | 20.02 - 21.54 |
| 52-Week Range | 16.15 - 24.32 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ATTO
Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments. The company's products include ATTO-1310, a novel ATTOBODY-based Fc-fusion protein therapeutic that inhibits IL-31; developed for the treatment of chronic pruritic diseases such as CPUO, high-itch ...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 5, 2026
Employees 44
Stock Exchange NasdaqGM
Ticker Symbol ATTO
Website https://www.attovia.com
Financial Performance
In 2025, Attovia Therapeutics's revenue was 1.35M, an increase of undefined% compared to the previous year's 0. Earnings were -60.63M, an increase of 52.33%.
Financial Statements
